Navigation Links
Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System

SAN JOSE, Calif., Oct. 31, 2011 /PRNewswire/ -- Baxano, Inc., a Silicon Valley based medical device company and manufacturer of the iO-Flex® System for spinal decompression surgery, announces a rapid expansion of its sales infrastructure to meet the surging demand for its products.

This continued expansion in the field infrastructure will help increase Baxano's reach into new and existing accounts throughout the U.S. while providing greater support to surgeons in their efforts to help treat a growing number of patients suffering from lumbar spinal stenosis (LSS), a disease that currently affects roughly 3 million adults annually.

Tony Recupero, President & CEO of Baxano, commented, "We are very optimistic about Baxano's current success and future prospects.  Our monthly sales have grown 300% during the first three quarters of 2011 and Q4 is showing even stronger growth rates.  We are expanding our sales coverage so that we can continue to deliver this very innovative technology to surgeons who are treating LSS patients."

Baxano's flagship iO-Flex® System is the first minimally invasive set of flexible instruments designed to target lumbar stenosis in the central canal, lateral recess and neural foramen, with minimal disruption to the patient's healthy anatomy. It is the only treatment alternative that is able to reach and remove tissue that creates pressure on multiple nerve roots through a single incision.

The Company is also currently enrolling patients in two separate post-market trials (iO-Flex Study and STRiDE) to further demonstrate outcomes and economics relative to traditional treatments for LSS.

About Baxano, Inc.

Baxano, Inc., based in San Jose, California, is a privately held company which was founded in 2005 with the vision to create flexible tools to provide precision lumbar decompression from the "inside out."  These important platform technologies will form the basis for future product offerings.  

Baxano's mission is to develop innovative tools that restore spine function, preserve healthy tissue, and enable a better quality of life for the patients we serve.

Along with our dedication to advanced technology development, Baxano is focused on providing exceptional value to patients, customers, investors and employees. For more information about Baxano and its products, please visit:

Amie Borgstrom
Vice President, Marketing
Phone: 408-514-2217

SOURCE Baxano, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
2. Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards
3. Baxano, Inc. Announces Close of $30 Million Series C Funding
4. GNS Healthcare, Inc. Expands Senior Management Team to Leverage the Rapidly Growing Opportunities for Big Data in Healthcare Management
5. Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad
6. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. Installation of Next Generation Proton Therapy System Progressing Rapidly
9. endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting
10. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
11. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
Post Your Comments:
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/26/2015)... ... ... Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, announces ... new Q-Suite 6 platform is based on the latest Java Enterprise standards. By conforming ... of software for many key components of the suite. Much of the suite runs ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part ... For Empowerment ™ attracts volunteers together who want to combine talents and resources ... key stakeholders in the process. The non-profit launched its first major fundraiser on ...
Breaking Medicine News(10 mins):